Company Information
USD
0.7
- (-5.4%)
NASDAQ:COSM, COSMOS HEALTH INC
Industry: Medical Distribution
End of Day: 16 May 2024 GMT-4
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers.
Address
141 West Jackson Boulevard
Suite 4236
Website
Classification
Sector
Healthcare
Industry Group
Medical Distribution
Industry
Medical Distribution
Key Executives
Mr. Nikos Bardakis
COO
Mr. Suhel Bhutawala
Director
Dr. Anastasios Aslidis,PhD
Director
Dr. Manfred Ziegler
Director
Mr. Grigorios Siokas
CEO/CEO, Subsidiary/Director/Other Corporate Officer
Mr. Georgios Terzis
CFO/Chief Accounting Officer
Mr. Demetrios G. Demetriades
Director/Secretary
Mr. John J. Hoidas
Director
Mr. Nikolaos Bardakis
COO
Ownership
Institution Holdings
Armistice Capital, LLC
1,334,937 (7.924%)
BlackRock Inc
290,699 (1.726%)
Vanguard Group Inc
134,834 (0.800%)
Geode Capital Management, LLC
101,290 (0.601%)
Fidelity Management & Research Company LLC
92,424 (0.549%)
Barclays Global Investors NA
40,810 (0.242%)
BlackRock
35,603 (0.211%)
Northern Trust Investments Inc
30,943 (0.184%)
JANE STREET GROUP, LLC
26,603 (0.158%)
State Street Corporation
24,743 (0.147%)
Funds Holdings
BlackRock Extended Equity Market
35,603 (0.211%)
Fidelity Series Total Market Index Fund
14,502 (0.086%)
NT Ext Equity Mkt Idx Fd - DC - NL
10,389 (0.062%)
Extended Equity Market Fund M
4,402 (0.026%)
NT Ext Equity Mkt Indx Fd DC Lending
418 (0.002%)
SSgA U.S. Total Market Index Fund
150 (0.001%)
Make Smart Investment Choices